{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470628187
| IUPAC_name = 3-allyl-''N''-(aminocarbonyl)-5-methyl-2-oxotetrahydrofuran-3-carboxamide
| image = Valofane.svg
| width = 180

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 3258-51-3
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 71122
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104479
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64272
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X71N6E5IPO

<!--Chemical data-->
| C=10 | H=14 | N=2 | O=4 
| molecular_weight = 226.229 g/mol
| smiles = O=C(N)NC(=O)C1(C(=O)OC(C)C1)C\C=C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H14N2O4/c1-3-4-10(7(13)12-9(11)15)5-6(2)16-8(10)14/h3,6H,1,4-5H2,2H3,(H3,11,12,13,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LVJAHKSVOQLCEV-UHFFFAOYSA-N
| synonyms = <small>''N''-carbamoyl-5-methyl-2-oxo-3-prop-2-enyloxolane-3-carboxamide</small>
}}

'''Valofane''' is a [[sedative]] drug structurally related to the [[barbiturate]]s<ref>Traversa U, Puppini P, Jacquot C, Vertua R. Effect of an atypical barbiturate, the 2-allophanyl-2-allyl-4-valerolactone (valofan), on exploratory behaviour and brain serotonin concentrations in mice. ''Journal de Pharmacologie''. 1985 Jul-Sep;16(3):279-90.</ref> and similar drugs such as [[primidone]]. It is metabolised once inside the body to form the barbiturate [[proxibarbital]] (proxibarbal) and is thus a [[prodrug]].<ref>Lambrey B, Compagnon PL, Jacquot C. Pharmacokinetics of 14C-2-allophanyl-2-allyl -gamma-valero-lactone: a prodrug of proxibarbal in rats. ''European Journal of Drug Metabolism and Pharmacokinetics''. 1981;6(3):161-9.</ref>

== References ==
<references />

{{Sedatives}}
{{GABAAR PAMs}}

[[Category:Allyl compounds]]
[[Category:Barbiturates]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Prodrugs]]
[[Category:Sedatives]]
[[Category:Tetrahydrofurans]]
[[Category:Lactones]]

{{nervous-system-drug-stub}}